Angiogenin induces modifications in the astrocyte secretome: Relevance to amyotrophic lateral sclerosis

Journal of Proteomics

Volumn 91, Issue , 2013, Pages 274-285

  Skorupa, Alexandra ^a,b,c   Urbach, Serge ^a,b   Vigy, Oana ^a,b   King, Matthew A ^c   Chaumont Dubel, Séverine ^a,b   Prehn, Jochen H M ^c   Marin, Philippe ^a,b  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^b UNIV MONTPELLIER   (France)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Amyotrophic lateral sclerosis; Angiogenin; Astrocyte; Secretome; SILAC

Indexed keywords

AMINO ACID; ANGIOGENIN; CHEMOKINE; CYTOKINE; PROTEINASE INHIBITOR;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; DISEASE COURSE; EXTRACELLULAR MATRIX; GENE IDENTIFICATION; ISOTOPE LABELING; LOSS OF FUNCTION MUTATION; MASS SPECTROMETRY; MICROGLIA; MOTONEURON; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; PROTEOMICS; WESTERN BLOTTING;

AMYOTROPHIC LATERAL SCLEROSIS; ANGIOGENIN; ASTROCYTE; SECRETOME; SILAC;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELL COMMUNICATION; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; MOTOR NEURONS; MUTATION; NEURONS; PROTEOME; PROTEOMICS; RIBONUCLEASE, PANCREATIC;

EID: 84883035843     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.07.028     Document Type: Article

References (64)

1. Nedergaard M., Ransom B., Goldman S.A. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 2003, 26:523-530.
2. Wang D.D., Bordey A. The astrocyte odyssey. Prog Neurobiol 2008, 86:342-367.
3. Allaman I., Belanger M., Magistretti P.J. Astrocyte-neuron metabolic relationships: for better and for worse. Trends Neurosci 2011, 34:76-87.
4. Perea G., Navarrete M., Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 2009, 32:421-431.
5. Halassa M.M., Florian C., Fellin T., Munoz J.R., Lee S.Y., Abel T., et al. Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 2009, 61:213-219.
6. Gibbs M.E., Hutchinson D., Hertz L. Astrocytic involvement in learning and memory consolidation. Neurosci Biobehav Rev 2008, 32:927-944.
7. Jha M.K., Seo M., Kim J.H., Kim B.G., Cho J.Y., Suk K. The secretome signature of reactive glial cells and its pathological implications. Biochim Biophys Acta 2013, [in press].
8. Greco T.M., Seeholzer S.H., Mak A., Spruce L., Ischiropoulos H. Quantitative mass spectrometry-based proteomics reveals the dynamic range of primary mouse astrocyte protein secretion. J Proteome Res 2010, 9:2764-2774.
9. Keene S.D., Greco T.M., Parastatidis I., Lee S.H., Hughes E.G., Balice-Gordon R.J., et al. Mass spectrometric and computational analysis of cytokine-induced alterations in the astrocyte secretome. Proteomics 2009, 9:768-782.
10. Dowell J.A., Johnson J.A., Li L. Identification of astrocyte secreted proteins with a combination of shotgun proteomics and bioinformatics. J Proteome Res 2009, 8:4135-4143.
11. Lafon-Cazal M., Adjali O., Galeotti N., Poncet J., Jouin P., Homburger V., et al. Proteomic analysis of astrocytic secretion in the mouse. Comparison with the cerebrospinal fluid proteome. J Biol Chem 2003, 278:24438-24448.
12. Moore N.H., Costa L.G., Shaffer S.A., Goodlett D.R., Guizzetti M. Shotgun proteomics implicates extracellular matrix proteins and protease systems in neuronal development induced by astrocyte cholinergic stimulation. J Neurochem 2009, 108:891-908.
13. Delcourt N., Jouin P., Poncet J., Demey E., Mauger E., Bockaert J., et al. Difference in mass analysis using labeled lysines (DIMAL-K): a new, efficient proteomic quantification method applied to the analysis of astrocytic secretomes. Mol Cell Proteomics 2005, 4:1085-1094.
14. Lai W., Wu J., Zou X., Xie J., Zhang L., Zhao X., et al. Secretome analyses of Abeta(1-42) stimulated hippocampal astrocytes reveal that CXCL10 is involved in astrocyte migration. J Proteome Res 2013, 12:832-843.
15. Boillee S., Vande Velde C., Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006, 52:39-59.
16. Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 2009, 187:761-772.
17. Pehar M., Vargas M.R., Cassina P., Barbeito A.G., Beckman J.S., Barbeito L. Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis. Neurodegener Dis 2005, 2:139-146.
18. Van Den Bosch L., Robberecht W. Crosstalk between astrocytes and motor neurons: what is the message?. Exp Neurol 2008, 211:1-6.
19. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001, 2:806-819.
20. Rosen D.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 364:362.
21. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
22. Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet 2006, 38:411-413.
23. Strydom D.J., Fett J.W., Lobb R.R., Alderman E.M., Bethune J.L., Riordan J.F., et al. Amino acid sequence of human tumor derived angiogenin. Biochemistry 1985, 24:5486-5494.
24. Moroianu J., Riordan J.F. Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc Natl Acad Sci U S A 1994, 91:1677-1681.
25. Kishimoto K., Liu S., Tsuji T., Olson K.A., Hu G.F. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 2005, 24:445-456.
26. Kieran D., Sebastia J., Greenway M.J., King M.A., Connaughton D., Concannon C.G., et al. Control of motoneuron survival by angiogenin. J Neurosci 2008, 28:14056-14061.
27. Sebastia J., Kieran D., Breen B., King M.A., Netteland D.F., Joyce D., et al. Angiogenin protects motoneurons against hypoxic injury. Cell Death Differ 2009, 16:1238-1247.
28. Skorupa A., King M.A., Aparicio I.M., Dussmann H., Coughlan K., Breen B., et al. Motoneurons secrete angiogenin to induce RNA cleavage in astroglia. J Neurosci 2012, 32:5024-5038.
29. Thouvenot E., Urbach S., Dantec C., Poncet J., Seveno M., Demettre E., et al. Enhanced detection of CNS cell secretome in plasma protein-depleted cerebrospinal fluid. J Proteome Res 2008, 7:4409-4421.
30. Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 2008, 26:1367-1372.
31. Cox J., Neuhauser N., Michalski A., Scheltema R.A., Olsen J.V., Mann M. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 2011, 10:1794-1805.
32. Team RDC R: a language and environment for statistical computing 2009, R Foundation for Statistical Computing, Vienna, Austria.
33. Thouvenot E., Urbach S., Vigy O., Seveno M., Galeotti N., Nguyen G., et al. Quantitative proteomic analysis reveals protein expression changes in the murine neuronal secretome during apoptosis. J Proteomics 2012, 77:394-405.
34. Maere S., Heymans K., Kuiper M. BiNGO: a cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 21:3448-3449.
35. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13:2498-2504.
36. Petersen T.N., Brunak S., von Heijne G., Nielsen H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 2011, 8:785-786.
37. Bendtsen J.D., Jensen L.J., Blom N., Von Heijne G., Brunak S. Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng Des Sel 2004, 17:349-356.
38. van der Meer J.W., Simon A. Blocking IL-1beta to slow down progression of ALS?. Proc Natl Acad Sci U S A 2010, 107:12741-12742.
39. Kim E.M., Shin E.J., Choi J.H., Son H.J., Park I.S., Joh T.H., et al. Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during endoplasmic reticulum stress. J Biol Chem 2010, 285:16444-16452.
40. Houi K., Kobayashi T., Kato S., Mochio S., Inoue K. Serum type IV collagen increases with duration of amyotrophic lateral sclerosis. Muscle Nerve 2000, 23:430-432.
41. Seeds N., Mikesell S., Vest R., Bugge T., Schaller K., Minor K. Plasminogen activator promotes recovery following spinal cord injury. Cell Mol Neurobiol 2011, 31:961-967.
42. Katsuno M., Adachi H., Banno H., Suzuki K., Tanaka F., Sobue G. Transforming growth factor-beta signaling in motor neuron diseases. Curr Mol Med 2011, 11:48-56.
43. Basso M., Pozzi S., Tortarolo M., Fiordaliso F., Bisighini C., Pasetto L., et al. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem 2013, 288:15699-15711.
44. Wang G., Dinkins M., He Q., Zhu G., Poirier C., Campbell A., et al. Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem 2012, 287:21384-21395.
45. Barreto G.E., Gonzalez J., Torres Y., Morales L. Astrocytic-neuronal crosstalk: implications for neuroprotection from brain injury. Neurosci Res 2011, 71:107-113.
46. Soeda S., Koyanagi S., Kuramoto Y., Kimura M., Oda M., Kozako T., et al. Anti-apoptotic roles of plasminogen activator inhibitor-1 as a neurotrophic factor in the central nervous system. Thromb Haemost 2008, 100:1014-1020.
47. Glas M., Popp B., Angele B., Koedel U., Chahli C., Schmalix W.A., et al. A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis. Exp Neurol 2007, 207:350-356.
48. Skonier J., Bennett K., Rothwell V., Kosowski S., Plowman G., Wallace P., et al. beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol 1994, 13:571-584.
49. Kim M.O., Yun S.J., Kim I.S., Sohn S., Lee E.H. Transforming growth factor-beta-inducible gene-h3 (beta(ig)-h3) promotes cell adhesion of human astrocytoma cells in vitro: implication of alpha6beta4 integrin. Neurosci Lett 2003, 336:93-96.
50. Hashimoto K., Noshiro M., Ohno S., Kawamoto T., Satakeda H., Akagawa Y., et al. Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/beta ig-h3) that binds to collagen. Biochim Biophys Acta 1997, 1355:303-314.
51. McLennan I.S., Koishi K. The transforming growth factor-betas: multifaceted regulators of the development and maintenance of skeletal muscles, motoneurons and Schwann cells. Int J Dev Biol 2002, 46:559-567.
52. Day W.A., Koishi K., Nukuda H., McLennan I.S. Transforming growth factor-beta 2 causes an acute improvement in the motor performance of transgenic ALS mice. Neurobiol Dis 2005, 19:323-330.
53. Choi D.H., Kim E.M., Son H.J., Joh T.H., Kim Y.S., Kim D., et al. A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells. J Neurochem 2008, 106:405-415.
54. Kim E.M., Hwang O. Role of matrix metalloproteinase-3 in neurodegeneration. J Neurochem 2011, 116:22-32.
55. Garbuzova-Davis S., Haller E., Saporta S., Kolomey I., Nicosia S.V., Sanberg P.R. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res 2007, 1157:126-137.
56. Garbuzova-Davis S., Rodrigues M.C., Hernandez-Ontiveros D.G., Louis M.K., Willing A.E., Borlongan C.V., et al. Amyotrophic lateral sclerosis: a neurovascular disease. Brain Res 2011, 1398:113-125.
57. Garbuzova-Davis S., Saporta S., Haller E., Kolomey I., Bennett S.P., Potter H., et al. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One 2007, 2:e1205.
58. Zhong Z., Deane R., Ali Z., Parisi M., Shapovalov Y., O'Banion M.K., et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 2008, 11:420-422.
59. Nicaise C., Mitrecic D., Demetter P., De Decker R., Authelet M., Boom A., et al. Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res 2009, 1301:152-162.
60. Evans M.C., Couch Y., Sibson N., Turner M.R. Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Mol Cell Neurosci 2012, 53:34-41.
61. Liesi P., Kauppila T. Induction of type IV collagen and other basement-membrane-associated proteins after spinal cord injury of the adult rat may participate in formation of the glial scar. Exp Neurol 2002, 173:31-45.
62. Johansen J.S., Schultz N.A., Jensen B.V. Plasma YKL-40: a potential new cancer biomarker?. Future Oncol 2009, 5:1065-1082.
63. Nguyen M.D., Julien J.P., Rivest S. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. Ann Neurol 2001, 50:630-639.
64. Okada K., Yamashita U., Tsuji S. Modulation of Na(+)-dependent glutamate transporter of murine astrocytes by inflammatory mediators. J UOEH 2005, 27:161-170.